EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Oral mucosa involvement in pediatric patients with xeroderma pigmentosum: a comprehensive review

Defne Baskurt iD, Secil Vural iD, Sümeyre S Ertekin iD, Can Baykal

International Journal of Dermatology · 2024

DOI: 10.1111/ijd.16890 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Dermatology, 2024. Verfasst von Defne Baskurt und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Koç University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Xeroderma Pigmentosum, Skin Neoplasms, Basal Cell Carcinoma, Melanoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Koç Üniversitesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Xeroderma pigmentosum (XP) is a rare autosomal recessive disorder presenting with an inability to repair UV‐induced DNA damage. This can lead to the development of neoplasms affecting multiple organ systems, with onset often in childhood. Unfortunately, no cure currently exists for XP, and management strategies focus on sun protection and early intervention for malignancies. Although most skin problems in XP patients are UV induced, various oral lesions are also described. However, the literature has not extensively characterized the oral manifestations and their prognostic significance.

Methods

We conducted a comprehensive review to evaluate the prevalence and nature of oral mucosal lesions in pediatric XP patients.

Results

Our literature search yielded 130 pediatric XP patients with oral involvement and 210 associated tumoral or non‐tumoral lesions. Squamous cell carcinoma was the most common type of oral mucosal tumor reported, with other malignancies including basal cell carcinoma, melanoma, angiosarcoma, fibrosarcoma, and trichilemmal carcinoma.

Conclusion

Given the potential morbidity and mortality associated with oral mucosal tumors in XP patients, our study aims to raise awareness of these manifestations. Early diagnosis and treatment are crucial for managing these lesions effectively, and routine oral exams should be considered a critical component of dermatological evaluations for XP patients, especially in the pediatric age group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Xeroderma PigmentosumSkin NeoplasmsBasal Cell CarcinomaMelanomaMouth NeoplasmsHumansChildMouth MucosaDNA Repair

Autor:innen und Institutionen

  • School of Medicine, Koç University, Istanbul, Turkey.
  • Department of Dermatology and Venereology, Koç University School of Medicine, Istanbul, Turkey.
  • Department of Dermatology and Venereology, Istanbul University, Faculty of Medicine, Istanbul, Turkey.

ORCID-Profile: Defne Baskurt, Secil Vural, Sümeyre S Ertekin

Förderung

  • Koç Üniversitesi

Zitieren

APA

Baskurt, D., Vural, S., Ertekin, S. S., & Baykal, C. (2024). Oral mucosa involvement in pediatric patients with xeroderma pigmentosum: a comprehensive review. International Journal of Dermatology. https://doi.org/10.1111/ijd.16890

Vancouver

Baskurt D, Vural S, Ertekin SS, Baykal C. Oral mucosa involvement in pediatric patients with xeroderma pigmentosum: a comprehensive review. International Journal of Dermatology. 2024. doi:10.1111/ijd.16890

BibTeX
@article{Baskurt2024,
  author = {Baskurt, Defne and Vural, Secil and Ertekin, Sümeyre S and Baykal, Can},
  title = {Oral mucosa involvement in pediatric patients with xeroderma pigmentosum: a comprehensive review},
  journal = {International Journal of Dermatology},
  year = {2024},
  doi = {10.1111/ijd.16890}
}
Kostenlos starten →